The role of National Institutes of Health category IV prostatitis in accurately staging the newly diagnosed prostate cancer


Aglamis E., Tasdemir C., Ceylan C.

IRISH JOURNAL OF MEDICAL SCIENCE, cilt.182, ss.463-467, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 182 Konu: 3
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s11845-013-0914-1
  • Dergi Adı: IRISH JOURNAL OF MEDICAL SCIENCE
  • Sayfa Sayıları: ss.463-467

Özet

It has been known that the National Institutes of Health category IV (NIH-IV) prostatitis increases the serum total prostate-specific antigen (tPSA) in patients with benign prostatic hyperplasia. However, the effect of NIH-IV prostatitis on tPSA levels, which are used for staging prostate cancer (PCa) in patients with PCa, has not been previously investigated.